📋 Forensic IPO Analysis: How to Decode a DRHP Before the Listing

Why Standard IPO Due Diligence Fails

Every IPO season, the same ritual plays out. Grey market premium numbers circulate in WhatsApp groups. Broker research notes arrive with buy recommendations and aggressive price targets. Anchor investor lists get published — look, top-tier funds are in it, how bad can it be? The subscription numbers come in at 70x on day two and investors pile in convinced they're holding a lottery ticket.

Then the listing happens. Sometimes it pops. More often, it quietly drifts. And three or six months later, the same company is trading 30% below the issue price while management talks about “challenging macro conditions” — the same conditions they somehow weren't worried about in the roadshow.

The DRHP — Draft Red Herring Prospectus — is the one document that contains everything SEBI requires the company to disclose. Revenue concentration. Customer dependencies. Regulatory risks. Promoter pledging. Related party transactions. Use of proceeds. Every material risk the company can foresee must be disclosed here. It is, in theory, the most honest document the company will ever publish about itself.

In practice, DRHPs run 300 to 600 pages. The risk factors section alone might be 80 pages of dense legalese. Revenue tables appear in multiple formats across multiple sections that may not reconcile with each other. The “Use of Proceeds” section can be a masterclass in purposeful vagueness — “general corporate purposes” can mean anything from strategic acquisitions to paying down promoter-level debt through complex structures that never appear explicitly in the document.

Individual investors do not read 400-page PDFs. They skim the executive summary, look at the financials table, check the issue price vs earnings, and make a decision. This is not a criticism — it's a structural reality. The DRHP is designed by teams of lawyers and investment bankers who understand exactly how most readers interact with it.

IPO Decoder exists to close this gap. You upload the DRHP. The AI reads all 400 pages. It is specifically instructed to find what an optimistic reading would miss.

IPO Decoder: Adversarial by Design

Most analysis tools try to give you a balanced view. IPO Decoder does not. The AI is explicitly instructed to adopt an adversarial framing — its job is to assume the prospectus is written to impress, and to find the specific points where the impressive narrative breaks down under scrutiny.

This is a deliberate design choice. The company's management, bankers, and legal team have spent months making the DRHP as attractive as possible. The anchor investors have done their own due diligence but have incentive to be in a marquee deal. The GMP reflects retail sentiment, not fundamental value. In this environment, you need analysis that leans in the opposite direction — skeptical by default, looking for specific evidence of problems rather than assembling a balanced case.

The output is structured across 7 sections and closes with a clean three-way verdict:

The verdict is not a buy or sell recommendation — it is a due diligence summary that tells you how much additional work the IPO requires and where to focus that work.

What AIA Pre-fills Automatically

Before you even open the AI, Finmagine AI Advisor has already extracted and structured the available data from Screener.in. For IPOs and recently listed companies, Screener shows restated pre-IPO financials for 3–5 years. AIA captures:

• Company name, sector, NSE/BSE codes
• Key metrics (P/E, market cap, ROCE, ROE once listed)
• Annual P&L, Balance Sheet, Cash Flow, Ratios (pre-IPO restated)
• Significant BSE announcements from the last 210 days
• Credit rating links if present

This pre-filled financial context supplements the DRHP analysis. The AI cross-references what Screener shows (which may use different accounting year conventions or restatement adjustments) against what the DRHP reports, and flags any material inconsistencies.

Finding and Uploading the DRHP or RHP

This is the one step that makes or breaks the analysis. IPO Decoder is designed around document access. Without the uploaded PDF, the AI works only from Screener's restated financials — useful context, but a fraction of what the DRHP contains. Sections 3, 4, 5, and 6 in particular require the prospectus document directly.

Where to Find the DRHP or RHP

Three reliable sources, in order of preference:

1. SEBI EDGAR — The authoritative source. Go to sebi.gov.in and navigate to the EDGAR portal. Search by company name. Filed DRHPs and RHPs are publicly available as PDFs. This is where the document is filed first and is often the most complete version.
2. NSE — Company Info → IPO Documents — NSE hosts the RHP (final prospectus) for listed companies. Navigate to nseindia.com, search for the company, go to Company Info and then IPO Documents. The NSE version is sometimes smaller (compressed) than the SEBI version.
3. BSE — Company Information — BSE also hosts IPO documents. Find the company on BSE, go to Corporate Filings. Note that some BSE links require a browser session and may not open correctly — try downloading directly from the page rather than opening in-browser.

How to Attach the PDF in Claude

1. Open Claude.ai in your browser (or the Claude desktop app)
2. Click the paperclip / attachment icon in the message input area
3. Select the DRHP or RHP PDF you downloaded
4. Wait for the upload to complete (large DRHPs can take 30–60 seconds)
5. Then paste and submit the IPO Decoder prompt from AIA

Claude's 200K context window can handle even the largest DRHPs (typically 300–600 pages). The AI will read the full document — not just skim it. Specifically, it focuses on: Notes to Restated Financial Statements, Risk Factors (company-specific risks, not boilerplate), Related Party Disclosures, Use of Proceeds, Corporate Governance and Management Remuneration, and the Promoter section.

What IPO Decoder Looks For: Section by Section

Section 1 — Business Reality Check

The first section cuts through the marketing language to describe what the company actually does, in terms that matter for an investor rather than a roadshow audience. It is not a restatement of the business description from the DRHP — it is an interrogation of the underlying business model's actual strengths and vulnerabilities.

Revenue concentration: The AI identifies the top 3 customers by revenue percentage. If this is undisclosed (common in SME IPOs), that itself is flagged. Any company where a single customer accounts for more than 15–20% of revenue carries meaningful concentration risk that the headline growth story may obscure.

Geographic concentration: If more than 60% of revenue comes from one region — domestic or international — this is flagged as a concentration risk with specific investment implications.

Dependency risks: Single supplier relationships, regulatory-dependent revenue streams (e.g., a company whose revenue depends on government contracts or SEBI-regulated fees), single product lines with no meaningful second product. These are named specifically — not generically described as “concentration risk.”

Moat verdict: One of two conclusions — STRUCTURAL (the business has IP, switching costs, network effects, or scale economics that create defensible advantage) or NARRATIVE-BASED (the competitive position relies on management claims that are not verifiable from the DRHP). Most IPO companies present narrative-based moats. That's not automatically a negative — early-stage businesses may not have moat metrics yet — but investors should know what they're buying.

Section 2 — Financial Forensics (Last 3 Years Pre-IPO)

This section forces a structured look at the restated financials from the DRHP, built into a clean table:

The specific red flags the AI is trained to raise:

• EBITDA margin expansion >5 percentage points in the final year before IPO — this is the single most common window-dressing signal. Companies approaching an IPO have strong incentive to show improving margins. Cost deferrals, revenue acceleration, or one-time gains can create a margin trajectory that is not sustainable post-listing.
• PAT growing but CFO flat or declining — earnings accruing on paper without generating cash. If a company is profitable but not generating operating cash flow, the profitability is accounting-driven, not real.
• Receivable or inventory days expanding while revenue grows — a company growing its top line by extending credit more aggressively or accumulating unsold inventory is not growing organically. The growth is fragile.
• Net debt not declining despite profitable operations — if the company has been consistently profitable for 3 years but remains heavily indebted, cash is leaking somewhere: related party loans, excessive promoter salaries, or off-balance-sheet structures.
• Related party transactions >10% of revenue — the entity names and amounts are required, not just the aggregate number.

Section 3 — Promoter & Management Audit

The promoter section of most DRHPs reads like a biography. IPO Decoder is designed to read it as a forensic document. Five specific checks:

Section 4 — Use of Proceeds

Every DRHP lists what the company intends to do with the fresh issue proceeds. IPO Decoder structures this into a table and applies flag thresholds:

The bottom-line question this section must answer: Is this IPO primarily funding the company's growth, or primarily funding exits for existing shareholders?

Section 5 — Valuation Sanity Check

This section compares the IPO's valuation to named, listed peers. The AI must identify actual peer companies — it cannot use “industry average” as a cop-out. The comparison covers PE, EV/EBITDA, and P/Sales against 3 relevant listed peers, and closes with a one-sentence verdict on whether the IPO premium over peers is justified by superior growth, margins, or moat.

Common finding: many SME and mid-cap IPOs price at significant premiums to listed peers with stronger track records, justified by projected future growth that exists only in management presentations.

Section 6 — Risk Factor Triage

DRHP risk factors sections typically contain 50–100 items, of which the majority are generic legal boilerplate applicable to any company in any sector. IPO Decoder's job here is to triage: identify the 3 risks that are genuinely company-specific — those that would not appear in a competitor's DRHP — and explain them in plain English with specific investment implications.

A risk like “we are subject to various regulatory requirements” is boilerplate. A risk like “our top customer accounts for 34% of revenue and has not renewed its contract for the upcoming year” is company-specific. Section 6 finds the latter and ignores the former.

Section 7 — IPO Verdict

The final section synthesises the preceding six into five axes and delivers the overall verdict:

Followed by COMPELLING / WATCHLIST / APPROACH WITH CAUTION and one paragraph identifying the single most important thing the investor must independently verify before applying — naming the specific number, document, or event to check.

What COMPELLING, WATCHLIST, and APPROACH WITH CAUTION Mean in Practice

The three-way verdict is not a buy/sell recommendation. Finmagine does not provide investment advice, and IPO Decoder is an analytical tool, not a trading signal. What the verdict tells you is how much additional work the IPO warrants and where to focus that work.

COMPELLING

The business has a clear model with documented revenue sources, the pre-IPO financials are clean (PAT converts to CFO, margins didn't spike artificially in the IPO year, no material RPT concerns), the promoters are funding growth rather than exiting, the valuation is in line with or below listed peers of similar quality, and the company-specific risks are manageable. You still need to make your own investment decision, but you are not going in blind with obvious blind spots.

WATCHLIST

One or two specific areas of concern that are not resolved by the DRHP. Common WATCHLIST scenarios: valuation is stretched relative to peers but the growth story is credible; OFS component is borderline; one financial metric is concerning but the rest are clean. The recommendation here is not to avoid the IPO but to monitor the specific concern post-listing, or to apply for a smaller initial position and build if the concern doesn't materialise.

APPROACH WITH CAUTION

Multiple red flags across sections. This verdict is not a prediction that the stock will fall — momentum and sentiment can carry even deeply flawed IPOs for months post-listing. It is a signal that the due diligence burden is high, and that the risk/reward at the IPO price does not compensate for the identified concerns. Many APPROACH WITH CAUTION IPOs do list well and then underperform 12–18 months later, which is precisely the scenario this verdict is designed to avoid.

IPO Decoder vs Red Flag Detector vs Forensic Governance

All three are forensic templates. The distinction is what document they read and what question they answer.

The recommended escalation path is: IPO Decoder → Red Flag Detector → Forensic Governance. Use the lighter tool first. Escalate only if it surfaces specific concerns in governance-intensive sections that warrant a deeper investigation with concall evidence.